Form
20-F þ
|
Form
40-F o
|
Yes
o
|
No
þ
|
EXFO
ELECTRO-OPTICAL ENGINEERING INC.
|
|
By:
/s/
Germain
Lamonde
Name:
Germain Lamonde
Title:
President and Chief Executive Officer
|
|
§ |
Sales
increase 17.1% to US$35.2 million from US$30.1 M in Q2
2006
|
§ |
GAAP
net earnings improve 96.5% to US$2.7 million from US$1.4 million
in Q2
2006
|
§ |
Gross
margin reaches 57.5% compared to 55.3% in Q2
2006
|
§ |
Seven
new products launched, mostly for broadband access, IPTV and next-gen
networks
|
Segmented
results:
|
Q2
2007
|
Q2
2006
|
Q1
2007
|
|||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||
Sales:
|
||||||||||
Telecom
Division
|
$
|
29,297
|
$
|
25,254
|
$
|
29,522
|
||||
Life
Sciences and Industrial Division
|
5,910
|
4,812
|
6,025
|
|||||||
Total
|
$
|
35,207
|
$
|
30,066
|
$
|
35,547
|
||||
Earnings
from operations:
|
||||||||||
Telecom
Division
|
$
|
1,078
|
$
|
1,220
|
$
|
1,803
|
||||
Life
Sciences and Industrial Division
|
1,003
|
188
|
956
|
|||||||
Total
|
$
|
2,081
|
$
|
1,408
|
$
|
2,759
|
||||
Other
selected information:
|
||||||||||
GAAP
net earnings
|
$
|
2,684
|
$
|
1,366
|
$
|
3,533
|
||||
Amortization
of intangible assets
|
$
|
630
|
$
|
1,136
|
$
|
882
|
||||
Stock-based
compensation costs
|
$
|
241
|
$
|
281
|
$
|
285
|
As
at
February
28,
2007
|
As
at
August
31,
2006
|
||||||
|
(unaudited)
|
||||||
Assets
|
|||||||
Current
assets
|
|||||||
Cash
|
$
|
9,108
|
$
|
6,853
|
|||
Short-term
investments
|
105,521
|
104,437
|
|||||
Accounts
receivable
|
|||||||
Trade,
less allowance for doubtful accounts of $272
($451
as at August 31, 2006)
|
21,793
|
20,891
|
|||||
Other
|
3,088
|
2,792
|
|||||
Income
taxes and tax credits recoverable
|
2,138
|
2,201
|
|||||
Inventories
(note 4)
|
23,428
|
24,623
|
|||||
Prepaid
expenses
|
1,191
|
1,404
|
|||||
166,267
|
163,201
|
||||||
Income
taxes and tax credits recoverable
|
1,309
|
476
|
|||||
Property,
plant and equipment
|
15,695
|
17,392
|
|||||
Intangible
assets
|
9,459
|
10,948
|
|||||
Goodwill
|
25,675
|
27,142
|
|||||
$
|
218,405
|
$
|
219,159
|
||||
Liabilities
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable and accrued liabilities (note 5)
|
$
|
19,302
|
$
|
17,337
|
|||
Deferred
revenue
|
2,089
|
1,772
|
|||||
Current
portion of long-term debt
|
104
|
107
|
|||||
21,495
|
19,216
|
||||||
Deferred
revenue
|
3,294
|
2,632
|
|||||
Government
grants
|
661
|
723
|
|||||
Long-term
debt
|
282
|
354
|
|||||
25,732
|
22,925
|
||||||
Contingency
(note 6)
|
|||||||
Shareholders’
Equity
|
|||||||
Share
capital
|
149,578
|
148,921
|
|||||
Contributed
surplus
|
4,101
|
3,776
|
|||||
Retained
earnings (note 7)
|
6,217
|
−
|
|||||
Cumulative
translation adjustment
|
32,777
|
43,537
|
|||||
192,673
|
196,234
|
||||||
$
|
218,405
|
$
|
219,159
|
Three
months ended
February
28, 2007
|
Six
months
ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months
ended
February
28, 2006
|
||||||||||
Sales
|
$
|
35,207
|
$
|
70,754
|
$
|
30,066
|
$
|
57,110
|
|||||
Cost
of sales (1,2)
|
14,970
|
30,199
|
13,440
|
25,504
|
|||||||||
Gross
margin
|
20,237
|
40,555
|
16,626
|
31,606
|
|||||||||
Operating
expenses
|
|||||||||||||
Selling
and administrative (1)
|
12,184
|
23,726
|
9,303
|
18,361
|
|||||||||
Net
research and development (1)
(note 8)
|
4,678
|
9,032
|
3,906
|
7,028
|
|||||||||
Amortization
of property, plant and equipment
|
664
|
1,445
|
873
|
1,769
|
|||||||||
Amortization
of intangible assets
|
630
|
1,512
|
1,136
|
2,357
|
|||||||||
Total
operating expenses
|
18,156
|
35,715
|
15,218
|
29,515
|
|||||||||
Earnings
from operations
|
2,081
|
4,840
|
1,408
|
2,091
|
|||||||||
Interest
and other income
|
1,105
|
2,277
|
828
|
1,383
|
|||||||||
Foreign
exchange gain (loss)
|
352
|
735
|
(213
|
)
|
(531
|
)
|
|||||||
Earnings
before income taxes
|
3,538
|
7,852
|
2,023
|
2,943
|
|||||||||
Income
taxes (note
9)
|
854
|
1,635
|
657
|
1,222
|
|||||||||
Net
earnings for the period
|
$
|
2,684
|
$
|
6,217
|
$
|
1,366
|
$
|
1,721
|
|||||
Basic
net earnings per share
|
$
|
0.04
|
$
|
0.09
|
$
|
0.02
|
$
|
0.03
|
|||||
Diluted
net earnings per share
|
$
|
0.04
|
$
|
0.09
|
$
|
0.02
|
$
|
0.02
|
|||||
Basic
weighted average number of shares outstanding
(000’s)
|
68,839
|
68,807
|
68,591
|
68,581
|
|||||||||
Diluted
weighted average number of shares outstanding (000’s)
(note
10)
|
69,546
|
69,465
|
69,152
|
69,105
|
|||||||||
(1) Stock-based
compensation costs included in:
|
|||||||||||||
Cost
of sales
|
$
|
27
|
$
|
61
|
$
|
30
|
$
|
72
|
|||||
Selling
and administrative
|
159
|
356
|
198
|
379
|
|||||||||
Net
research and development
|
55
|
109
|
53
|
104
|
|||||||||
$
|
241
|
$
|
526
|
$
|
281
|
$
|
555
|
Retained
earnings (Deficit)
|
|||||||
Six
months ended
February
28,
|
|||||||
2007
|
2006
|
||||||
Balance
- Beginning of period
(note 7)
|
$
|
−
|
$
|
(381,846
|
)
|
||
Add
|
|||||||
Net
earnings for the period
|
6,217
|
1,721
|
|||||
Balance
- End of period
|
$
|
6,217
|
$
|
(380,125
|
)
|
Contributed
surplus
|
|||||||
Six
months ended
February
28,
|
|||||||
2007
|
2006
|
||||||
Balance
- Beginning of period
|
$
|
3,776
|
$
|
2,949
|
|||
Add
(deduct)
|
|||||||
Stock-based
compensation costs
|
499
|
555
|
|||||
Reclassification
of stock-based compensation costs to share capital upon exercise
of stock
awards
|
(174
|
)
|
−
|
||||
Balance
- End of period
|
$
|
4,101
|
$
|
3,504
|
Three
months ended
February
28, 2007
|
Six
months
ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months
ended
February
28, 2006
|
||||||||||
Cash
flows from operating activities
|
|||||||||||||
Net
earnings for the period
|
$
|
2,684
|
$
|
6,217
|
$
|
1,366
|
$
|
1,721
|
|||||
Add
(deduct) items not affecting cash
|
|||||||||||||
Discount
on short-term investments
|
364
|
778
|
447
|
618
|
|||||||||
Stock-based
compensation costs
|
241
|
526
|
281
|
555
|
|||||||||
Amortization
|
1,294
|
2,957
|
2,009
|
4,126
|
|||||||||
Deferred
revenue
|
745
|
1,239
|
(193
|
)
|
100
|
||||||||
Government
grants
|
−
|
(22
|
)
|
−
|
−
|
||||||||
5,328
|
11,695
|
3,910
|
7,120
|
||||||||||
Change
in non-cash operating items
|
|||||||||||||
Accounts
receivable
|
(210
|
)
|
(3,245
|
)
|
4,120
|
927
|
|||||||
Income
taxes and tax credits
|
(513
|
)
|
(931
|
)
|
(461
|
)
|
(749
|
)
|
|||||
Inventories
|
(510
|
)
|
(129
|
)
|
(1,775
|
)
|
(2,908
|
)
|
|||||
Prepaid
expenses
|
133
|
135
|
88
|
(28
|
)
|
||||||||
Accounts
payable and accrued liabilities
|
2,736
|
2,772
|
(446
|
)
|
1,972
|
||||||||
6,964
|
10,297
|
5,436
|
6,334
|
||||||||||
Cash
flows from investing activities
|
|||||||||||||
Additions
to short-term investments
|
(296,237
|
)
|
(490,503
|
)
|
(279,670
|
)
|
(411,045
|
)
|
|||||
Proceeds
from disposal and maturity of short-term investments
|
291,413
|
482,916
|
288,500
|
420,899
|
|||||||||
Additions
to property, plant and equipment and intangible assets
|
(835
|
)
|
(1,646
|
)
|
(933
|
)
|
(1,568
|
)
|
|||||
Net
proceeds from disposal of property, plant and equipment
|
−
|
1,228
|
−
|
−
|
|||||||||
Business
combination (note 3)
|
−
|
−
|
(17,497
|
)
|
(17,497
|
)
|
|||||||
(5,659
|
)
|
(8,005
|
)
|
(9,600
|
)
|
(9,211
|
)
|
||||||
Cash
flows from financing activities
|
|||||||||||||
Repayment
of long-term debt
|
(24
|
)
|
(51
|
)
|
(42
|
)
|
(74
|
)
|
|||||
Exercise
of stock options
|
362
|
483
|
137
|
156
|
|||||||||
338
|
432
|
95
|
82
|
||||||||||
Effect
of foreign exchange rate changes on cash
|
(276
|
)
|
(469
|
)
|
359
|
453
|
|||||||
Change
in cash
|
1,367
|
2,255
|
(3,710
|
)
|
(2,342
|
)
|
|||||||
Cash
- Beginning of period
|
7,741
|
6,853
|
8,487
|
7,119
|
|||||||||
Cash
- End of period
|
$
|
9,108
|
$
|
9,108
|
$
|
4,777
|
$
|
4,777
|
1. |
Interim
financial information
|
2. |
New
accounting standards and
pronouncements
|
3. |
Business
Combination
|
Assets
acquired
|
||||
Current
assets
|
$
|
5,135
|
||
Property,
plant and equipment
|
3,115
|
|||
Core
technology
|
8,709
|
|||
Current
liabilities assumed
|
(2,826
|
)
|
||
Loans
assumed
|
(402
|
)
|
||
Net
identifiable assets acquired
|
13,731
|
|||
Goodwill
|
5,107
|
|||
Purchase
price, net of cash acquired
|
$
|
18,838
|
4. |
Inventories
|
As
at
February
28,
2007
|
As
at
August
31,
2006
|
||||||
(unaudited)
|
|||||||
Raw
materials
|
$
|
12,828
|
$
|
14,353
|
|||
Work
in progress
|
1,226
|
1,043
|
|||||
Finished
goods
|
9,374
|
9,227
|
|||||
$
|
23,428
|
$
|
24,623
|
5. |
Accounts
payable and accrued liabilities
|
As
at
February
28,
2007
|
As
at
August
31,
2006
|
||||||
(unaudited)
|
|||||||
Trade
|
$
|
9,848
|
$
|
7,487
|
|||
Salaries
and social benefits
|
6,174
|
5,991
|
|||||
Warranty
|
789
|
1,006
|
|||||
Commissions
|
1,014
|
835
|
|||||
Restructuring
charges
|
174
|
691
|
|||||
Other
|
1,303
|
1,327
|
|||||
$
|
19,302
|
$
|
17,337
|
Six
months ended February 28,
|
|||||||
2007
|
2006
|
||||||
(unaudited)
|
|||||||
Balance
- Beginning of period
|
$
|
1,006
|
$
|
725
|
|||
Provision
|
408
|
543
|
|||||
Settlements
|
(625
|
)
|
(440
|
)
|
|||
Addition
from business combination
|
−
|
31
|
|||||
Balance
- End of period
|
$
|
789
|
$
|
859
|
Balance
as at
August
31,
2006
|
Payments
|
Balance
as at
February
28,
2007
|
||||||||
(unaudited)
|
(unaudited)
|
|||||||||
Fiscal
2006 plan
|
||||||||||
Severance
expenses
|
$
|
631
|
$
|
(472
|
)
|
$
|
159
|
|||
Fiscal
2003 plan
|
||||||||||
Exited
leased facilities
|
60
|
(45
|
)
|
15
|
||||||
Total
for all plans
|
$
|
691
|
$
|
(517
|
)
|
$
|
174
|
6. |
Contingency
|
7. |
Elimination
of deficit
|
8. |
Net
research and development
expenses
|
Three
months ended
February
28, 2007
|
Six
months ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months ended
February
28, 2006
|
||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||
Gross
research and development expenses
|
$
|
5,939
|
$
|
11,448
|
$
|
4,940
|
$
|
8,946
|
|||||
Research
and development tax credits and grants
|
(1,261
|
)
|
(2,416
|
)
|
(1,034
|
)
|
(1,918
|
)
|
|||||
$
|
4,678
|
$
|
9,032
|
$
|
3,906
|
$
|
7,028
|
9. |
Income
taxes
|
10. |
Earnings
per share
|
Three
months ended
February
28, 2007
|
Six
months
ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months
ended
February
28, 2006
|
||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,839
|
68,807
|
68,591
|
68,581
|
|||||||||
Plus
dilutive effect of:
|
|||||||||||||
Stock
options (000’s)
|
468
|
451
|
466
|
446
|
|||||||||
Restricted
share units (000’s)
|
190
|
161
|
65
|
51
|
|||||||||
Deferred
share units (000’s)
|
49
|
46
|
30
|
27
|
|||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,546
|
69,465
|
69,152
|
69,105
|
|||||||||
Stock
awards excluded from the calculation of diluted weighted average
number of
shares outstanding because their exercise price was greater than
the
average market price of the common shares (000’s)
|
1,213
|
1,299
|
1,829
|
1,816
|
11. |
Segment
information
|
Three
months ended February 28, 2007
|
Six
months ended February 28, 2007
|
||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||||||||
Sales
|
$
|
29,297
|
$
|
5,910
|
$
|
35,207
|
$
|
58,819
|
$
|
11,935
|
$
|
70,754
|
|||||||
Earnings
from operations
|
$
|
1,078
|
$
|
1,003
|
$
|
2,081
|
$
|
2,881
|
$
|
1,959
|
$
|
4,840
|
|||||||
Unallocated
items:
|
|||||||||||||||||||
Interest
and other income
|
1,105
|
2,277
|
|||||||||||||||||
Foreign
exchange gain
|
352
|
735
|
|||||||||||||||||
Earnings
before income taxes
|
3,538
|
7,852
|
|||||||||||||||||
Income
taxes
|
854
|
1,635
|
|||||||||||||||||
Net
earnings for the period
|
$
|
2,684
|
$
|
6,217
|
Three
months ended February 28, 2006
|
Six
months ended February 28, 2006
|
||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
||||||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||||||||
Sales
|
$
|
25,254
|
$
|
4,812
|
$
|
30,066
|
$
|
47,330
|
$
|
9,780
|
$
|
57,110
|
|||||||
Earnings
from operations
|
$
|
1,220
|
$
|
188
|
$
|
1,408
|
$
|
1,708
|
$
|
383
|
$
|
2,091
|
|||||||
Unallocated
items:
|
|||||||||||||||||||
Interest
and other income
|
828
|
1,383
|
|||||||||||||||||
Foreign exchange loss
|
(213
|
)
|
(531
|
)
|
|||||||||||||||
Earnings
before income taxes
|
2,023
|
2,943
|
|||||||||||||||||
Income
taxes
|
657
|
1,222
|
|||||||||||||||||
Net
earnings for the period
|
$
|
1,366
|
$
|
1,721
|
As
at
February
28,
2007
|
As
at
August
31,
2006
|
||||||
(unaudited)
|
|||||||
Total
assets
|
|||||||
Telecom
Division
|
$
|
91,124
|
$
|
93,853
|
|||
Life
Sciences and Industrial Division
|
9,205
|
11,339
|
|||||
Unallocated
assets
|
118,076
|
113,967
|
|||||
$
|
218,405
|
$
|
219,159
|
12. |
Stock-based
compensation
|
13. |
Differences
between Canadian and U.S. GAAP
|
Three
months ended
February
28, 2007
|
Six
months ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months ended
February
28, 2006
|
||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||
Net
earnings for the period in accordance with Canadian GAAP and U.S.
GAAP
|
$
|
2,684
|
$
|
6,217
|
$
|
1,366
|
$
|
1,721
|
|||||
Other
comprehensive income (loss)
|
|||||||||||||
Foreign
currency translation adjustment
|
(4,472
|
)
|
(10,304
|
)
|
4,263
|
7,311
|
|||||||
Unrealized
gains (losses) on forward exchange contracts
|
(3,718
|
)
|
(5,793
|
)
|
1,699
|
2,796
|
|||||||
Reclassification
of realized gains on forward exchange contracts in net
earnings
|
(108
|
)
|
(844
|
)
|
(582
|
)
|
(1,017
|
)
|
|||||
Comprehensive
income (loss) under U.S. GAAP
|
$
|
(5,614
|
)
|
$
|
(10,724
|
)
|
$
|
6,746
|
$
|
10,811
|
As
at
February
28,
2007
|
As
at
August
31,
2006
|
||||||
(unaudited)
|
|||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$
|
192,673
|
$
|
196,234
|
|||
Forward
exchange contracts
|
(1,186
|
)
|
5,451
|
||||
Goodwill
|
(11,465
|
)
|
(11,908
|
)
|
|||
Shareholders’
equity in accordance with U.S. GAAP
|
$
|
180,022
|
$
|
189,777
|
Share
capital
|
Contributed
surplus
|
Deficit
|
Deferred
stock-based
compensation costs
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
||||||||||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||||||||
Balance as at August 31, 2006
|
$
|
598,421
|
$
|
1,537
|
$
|
(458,944
|
)
|
$
|
(1,371
|
)
|
$
|
5,504
|
$
|
44,630
|
$
|
189,777
|
||||||
Net earnings for the period
|
−
|
−
|
3,533
|
−
|
−
|
−
|
3,533
|
|||||||||||||||
Stock-based compensation costs
|
−
|
−
|
−
|
(347
|
)
|
593
|
−
|
246
|
||||||||||||||
Foreign currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
(5,832
|
)
|
(5,832
|
)
|
|||||||||||||
Unrealized losses on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
(2,811
|
)
|
(2,811
|
)
|
|||||||||||||
Exercise of stock options
|
121
|
−
|
−
|
−
|
−
|
−
|
121
|
|||||||||||||||
Reclassification of stock-based compensation costs upon exercise
of stock
awards
|
47
|
−
|
−
|
−
|
(47
|
)
|
−
|
−
|
||||||||||||||
Balance as at November 30, 2006
|
$
|
598,589
|
$
|
1,537
|
$
|
(455,411
|
)
|
$
|
(1,718
|
)
|
$
|
6,050
|
$
|
35,987
|
$
|
185,034
|
||||||
Net earnings for the period
|
−
|
−
|
2,684
|
−
|
−
|
−
|
2,684
|
|||||||||||||||
Stock-based compensation costs
|
−
|
−
|
−
|
(510
|
)
|
750
|
−
|
240
|
||||||||||||||
Foreign currency translation adjustment
|
−
|
−
|
−
|
−
|
−
|
(4,472
|
)
|
(4,472
|
)
|
|||||||||||||
Unrealized losses on forward exchange contracts
|
−
|
−
|
−
|
−
|
−
|
(3,826
|
)
|
(3,826
|
)
|
|||||||||||||
Exercise of stock options
|
362
|
−
|
−
|
−
|
−
|
−
|
362
|
|||||||||||||||
Reclassification of stock-based compensation costs upon exercise
of
stock awards
|
127
|
−
|
−
|
−
|
(127
|
)
|
−
|
−
|
||||||||||||||
Balance as at February 28, 2007
|
$
|
599,078
|
$
|
1,537
|
$
|
(452,727
|
)
|
$
|
(2,228
|
)
|
$
|
6,673
|
$
|
27,689
|
$
|
180,022
|
As
at
February
28,
2007
|
As
at
August
31,
2006
|
||||||
(unaudited)
|
|||||||
Foreign
currency translation adjustment
|
|||||||
Current
period
|
$
|
(10,304
|
)
|
$
|
12,322
|
||
Cumulative
effect of prior periods
|
39,179
|
26,857
|
|||||
28,875
|
39,179
|
||||||
Unrealized
gains (losses) on forward exchange contracts
|
|||||||
Current
period
|
(6,637
|
)
|
2,514
|
||||
Cumulative
effect of prior periods
|
5,451
|
2,937
|
|||||
(1,186
|
)
|
5,451
|
|||||
$
|
27,689
|
$
|
44,630
|
Three
months ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months
ended
February
28, 2007
|
Six
months
ended
February
28, 2006
|
||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||
Sales
|
$
|
35,207
|
$
|
30,066
|
$
|
70,754
|
$
|
57,110
|
|||||
Cost
of sales (1)
|
14,970
|
13,440
|
30,199
|
25,504
|
|||||||||
Gross
margin
|
20,237
|
16,626
|
40,555
|
31,606
|
|||||||||
Operating
expenses
|
|||||||||||||
Selling
and administrative
|
12,184
|
9,303
|
23,726
|
18,361
|
|||||||||
Net
research and development
|
4,678
|
3,906
|
9,032
|
7,028
|
|||||||||
Amortization
of property, plant and equipment
|
664
|
873
|
1,445
|
1,769
|
|||||||||
Amortization
of intangible assets
|
630
|
1,136
|
1,512
|
2,357
|
|||||||||
Total
operating expenses
|
18,156
|
15,218
|
35,715
|
29,515
|
|||||||||
Earnings
from operations
|
2,081
|
1,408
|
4,840
|
2,091
|
|||||||||
Interest
and other income
|
1,105
|
828
|
2,277
|
1,383
|
|||||||||
Foreign
exchange gain (loss)
|
352
|
(213
|
)
|
735
|
(531
|
)
|
|||||||
Earnings
before income taxes
|
3,538
|
2,023
|
7,852
|
2,943
|
|||||||||
Income
taxes
|
854
|
657
|
1,635
|
1,222
|
|||||||||
Net
earnings for the period
|
$
|
2,684
|
$
|
1,366
|
$
|
6,217
|
$
|
1,721
|
|||||
Basic
net earnings per share
|
$
|
0.04
|
$
|
0.02
|
$
|
0.09
|
$
|
0.03
|
|||||
Diluted
net earnings per share
|
$
|
0.04
|
$
|
0.02
|
$
|
0.09
|
$
|
0.02
|
|||||
Segmented
information:
|
|||||||||||||
Sales:
|
|||||||||||||
Telecom
Division
|
$
|
29,297
|
$
|
25,254
|
$
|
58,819
|
$
|
47,330
|
|||||
Life
Sciences and Industrial Division
|
5,910
|
4,812
|
11,935
|
9,780
|
|||||||||
$
|
35,207
|
$
|
30,066
|
$
|
70,754
|
$
|
57,110
|
||||||
Earnings
from operations:
|
|||||||||||||
Telecom
Division
|
$
|
1,078
|
$
|
1,220
|
$
|
2,881
|
$
|
1,708
|
|||||
Life
Sciences and Industrial Division
|
1,003
|
188
|
1,959
|
383
|
|||||||||
$
|
2,081
|
$
|
1,408
|
$
|
4,840
|
$
|
2,091
|
||||||
Research
and development data:
|
|||||||||||||
Gross
research and development
|
$
|
5,939
|
$
|
4,940
|
$
|
11,448
|
$
|
8,946
|
|||||
Net
research and development
|
$
|
4,678
|
$
|
3,906
|
$
|
9,032
|
$
|
7,028
|
Three
months ended
February
28, 2007
|
Three
months ended
February
28, 2006
|
Six
months
ended
February
28, 2007
|
Six
months
ended
February
28, 2006
|
||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||
Sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
|||||
Cost
of sales (1)
|
42.5
|
44.7
|
42.7
|
44.7
|
|||||||||
Gross
margin
|
57.5
|
55.3
|
57.3
|
55.3
|
|||||||||
Operating
expenses
|
|||||||||||||
Selling
and administrative
|
34.6
|
30.9
|
33.5
|
32.2
|
|||||||||
Net
research and development
|
13.3
|
13.0
|
12.8
|
12.3
|
|||||||||
Amortization
of property, plant and equipment
|
1.9
|
2.9
|
2.0
|
3.0
|
|||||||||
Amortization
of intangible assets
|
1.8
|
3.8
|
2.2
|
4.1
|
|||||||||
Total
operating expenses
|
51.6
|
50.6
|
50.5
|
51.6
|
|||||||||
Earnings
from operations
|
5.9
|
4.7
|
6.8
|
3.7
|
|||||||||
Interest
and other income
|
3.1
|
2.7
|
3.2
|
2.4
|
|||||||||
Foreign
exchange gain (loss)
|
1.0
|
(0.7
|
)
|
1.1
|
(0.9
|
)
|
|||||||
Earnings
before income taxes
|
10.0
|
6.7
|
11.1
|
5.2
|
|||||||||
Income
taxes
|
2.4
|
2.2
|
2.3
|
2.2
|
|||||||||
Net
earnings for the period
|
7.6
|
%
|
4.5
|
%
|
8.8
|
%
|
3.0
|
%
|
|||||
Segmented
information:
|
|||||||||||||
Sales:
|
|||||||||||||
Telecom
Division
|
83.2
|
%
|
84.0
|
%
|
83.1
|
%
|
82.9
|
%
|
|||||
Life
Sciences and Industrial Division
|
16.8
|
16.0
|
16.9
|
17.1
|
|||||||||
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||
Earnings
from operations:
|
|||||||||||||
Telecom
Division
|
3.1
|
%
|
4.1
|
%
|
4.1
|
%
|
3.0
|
%
|
|||||
Life
Sciences and Industrial Division
|
2.8
|
0.6
|
2.7
|
0.7
|
|||||||||
5.9
|
%
|
4.7
|
%
|
6.8
|
%
|
3.7
|
%
|
||||||
Research
and development data:
|
|||||||||||||
Gross
research and development
|
16.9
|
%
|
16.4
|
%
|
16.2
|
%
|
15.7
|
%
|
|||||
Net
research and development
|
13.3
|
%
|
13.0
|
%
|
12.8
|
%
|
12.3
|
%
|
Expiry
dates
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
||
March
2007 to August 2007
|
$21,700,000
|
1.1520
|
||
September
2007 to December 2009
|
$48,300,000
|
1.1312
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
|||
Chairman
of the Board, President and CEO (one
individual)
|
179,642
|
8%
|
$9.05
|
|||
Board
of Directors (five individuals)
|
194,375
|
9%
|
$6.23
|
|||
Management
and Corporate Officers (eight
individuals)
|
297,718
|
14%
|
$16.10
|
|||
671,735
|
31%
|
$11.36
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
||||
Chairman
of the Board, President and CEO (one
individual)
|
59,913
|
11%
|
||||
Management
and Corporate Officers (ten
individuals)
|
272,399
|
52%
|
||||
332,312
|
63%
|
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
||||
Board
of Directors (five individuals)
|
54,305
|
100%
|
Q2-FY07
|
Q1-FY07
|
Q4-FY06
|
Q3-FY06
|
||||||||||
Sales
|
$
|
35,207
|
$
|
35,547
|
$
|
35,733
|
$
|
35,410
|
|||||
Cost
of sales
|
$
|
14,970
|
$
|
15,229
|
$
|
16,318
|
$
|
15,453
|
|||||
Gross
margin
|
$
|
20,237
|
$
|
20,318
|
$
|
19,415
|
$
|
19,957
|
|||||
Earnings
from operations
|
$
|
2,081
|
$
|
2,759
|
$
|
2,363
|
$
|
3,608
|
|||||
Net
earnings
|
$
|
2,684
|
$
|
3,533
|
$
|
2,910
|
$
|
3,504
|
|||||
Basic
and diluted net earnings per share
|
$
|
0.04
|
$
|
0.05
|
$
|
0.04
|
$
|
0.05
|
Q2-FY06
|
Q1-FY06
|
Q4-FY05
|
Q3-FY05
|
||||||||||
Sales
|
$
|
30,066
|
$
|
27,044
|
$
|
26,304
|
$
|
26,180
|
|||||
Cost
of sales
|
$
|
13,440
|
$
|
12,064
|
$
|
11,925
|
$
|
11,478
|
|||||
Gross
margin
|
$
|
16,626
|
$
|
14,980
|
$
|
14,379
|
$
|
14,702
|
|||||
Earnings
from operations
|
$
|
1,408
|
$
|
683
|
$
|
811
|
$
|
509
|
|||||
Net
earnings
|
$
|
1,366
|
$
|
355
|
$
|
454
|
$
|
276
|
|||||
Basic
and diluted net earnings per share
|
$
|
0.02
|
$
|
0.01
|
$
|
0.01
|
$
|
−
|